GRIFFIN THOMAS E 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Dec 16, 2019
Insider Transaction Report
Form 4
GRIFFIN THOMAS E
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-12-07−20,000→ 0 totalExercise: $4.98Exp: 2020-08-08→ Class A Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2019-12-07+20,000→ 20,000 totalExercise: $4.98Exp: 2026-08-08→ Class A Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These two reported transactions involved an amendment of an outstanding option originally granted on August 8, 2016 resulting in the deemed cancellation of the August 8, 2016 option and the grant of a replacement option with the same terms other than the expiration date.
- [F2]Immediately exercisable.